<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/90AE79EB-76AE-4C76-91EA-6CFFB6268480"><gtr:id>90AE79EB-76AE-4C76-91EA-6CFFB6268480</gtr:id><gtr:firstName>Tariq</gtr:firstName><gtr:surname>Enver</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_qA137913"><gtr:id>BACACFFA-79D3-4603-9BBF-FE3194E54B33</gtr:id><gtr:title>Understanding The Molecular Activation Of Stem Cells (UNMASC)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_qA137913</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>VASTox and collaborators at the MRC propose an innovative, high-throughput, in vivo screening programme to identify chemical modifiers of stem cell behaviour. Expected outputs include
compounds which affect stem cell proliferation, differentiation and behaviour that can be applied directly to most regenerative medicine fields, including in vivo blood regeneration, ex vivo cell expansion and maintenance, and as bioactive factors on scaffolds. In addition, tool compounds, an enabling technology for basic research, will be identified and will be made available to the wider scientific community. Commercialisation will involve partnering with industry leaders in regenerative medicine technologies. The project will contribute basic knowledge to most areas of regenerative medicine whilst also contributing to the UK economy and research base, ensuring that we stay at the forefront of stem cell research.</gtr:technicalSummary><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>191964</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8F80C498-3903-494D-B51B-531BD216FB5F</gtr:id><gtr:title>Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/671e845978dfdb3c1fa61c3e24a55ecb"><gtr:id>671e845978dfdb3c1fa61c3e24a55ecb</gtr:id><gtr:otherNames>Yogev O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546339bb6f05e0.24666861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0031AA2E-8504-4185-9C74-BF6471986B9D</gtr:id><gtr:title>Early dynamic fate changes in haemogenic endothelium characterized at the single-cell level.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2fe1df1f1c0d6bc5a40a742a0e29c6"><gtr:id>fe2fe1df1f1c0d6bc5a40a742a0e29c6</gtr:id><gtr:otherNames>Swiers G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>546339bc4deef6.55612195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07052B32-6F37-4313-9DFD-DF9E4A37F960</gtr:id><gtr:title>Stem cell programs are retained in human leukemic lymphoblasts.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4a0a4fdee23ea81e31252ff73e9aa74"><gtr:id>e4a0a4fdee23ea81e31252ff73e9aa74</gtr:id><gtr:otherNames>Fan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>546339bbeef1e7.38827148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7E2F406-CD1C-4CFA-AE40-022C25FD6E5A</gtr:id><gtr:title>Acute loss of Cited2 impairs Nanog expression and decreases self-renewal of mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a50e6d0799dc3fd6dbb34f263987df"><gtr:id>53a50e6d0799dc3fd6dbb34f263987df</gtr:id><gtr:otherNames>Kranc KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>546338d3a7a198.03553659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>869631EB-ED8A-4712-9AE0-93CCDD968EAA</gtr:id><gtr:title>Single-cell PCR profiling of gene expression in hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e82aa2fda95e6d5392514b422955d2"><gtr:id>32e82aa2fda95e6d5392514b422955d2</gtr:id><gtr:otherNames>Teles J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>546339bc2189b9.45539861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFB8A437-A695-49EA-9A6F-273230B64DFE</gtr:id><gtr:title>Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec540d396589c835fdbd03ad39ca12"><gtr:id>6aec540d396589c835fdbd03ad39ca12</gtr:id><gtr:otherNames>Patel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>546339bb969d10.04121146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0F43009-E47A-4232-A84B-3B9EDFE21964</gtr:id><gtr:title>Leukemia propagating cells rebuild an evolving niche in response to therapy.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2044b9c025cd6f61a6487016d07ef41d"><gtr:id>2044b9c025cd6f61a6487016d07ef41d</gtr:id><gtr:otherNames>Duan CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>546339bbc8bb83.35796680</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_qA137913</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>